VentriPoint Diagnostics Ltd:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:VentriPoint Diagnostics Ltd - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10306
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
VentriPoint Diagnostics Ltd (Ventripoint) is a medical device company that manufactures and distributes diagnostic tools and monitoring devices for patients with heart diseases. The company provides ventripoint diagnostic system, which is a cardiovascular monitoring and measurement device. Its manufactured device offers three-dimensional models and volume measurements of the heart ventricles using 2D and 3D imaging equipment. VentriPoint uses knowledge based reconstruction technology that provides a method for rapid measurement of right ventricular volume and function in patients with congenital heart disease. The company markets its products through its distributors in the US, Canada, and other countries. VentriPoint is headquartered in Toronto, Ontario, the Cannada.

VentriPoint Diagnostics Ltd – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
VentriPoint Diagnostics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
VentriPoint Diagnostics Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
VentriPoint Diagnostics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
VentriPoint Diagnostics Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
VentriPoint Diagnostics Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
VentriPoint Diagnostics Ltd, Medical Equipment, Deal Details 10
Partnerships 10
VentriPoint Diagnostics Enters into Licensing Agreement with University of Washington 10
VentriPoint Diagnostics Enters Into Co-Development Agreement For 2D Ultrasound-VMS 11
Equity Offering 12
VentriPoint Diagnostics Raise USD0.3 Million in Private Placement of Units 12
Ventripoint Diagnostics to Raise USD2.4 Million in Private Placement of Units 13
Ventripoint Diagnostics Raises USD0.2 Million in First Tranche Private Placement of Shares 14
Ventripoint Diagnostics Raises USD2.3 Million in Private Placement of Units 15
Ventripoint Diagnostics to Raise USD3.7 Million in Private Placement of Units 16
VentriPoint Diagnostics Raises USD1.75 Million in First Tranche of Private Placement of Units 17
VentriPoint Diagnostics Completes Second Tranche Of Private Placement Of Units For US$0.05 Million 19
VentriPoint Completes Second Tranche Of Private Placement Of Units For US$0.35 Million 21
VentriPoint Diagnostics Completes Final Tranche Private Placement Of Units For US$1.6 Million 22
Debt Offering 23
VentriPoint Diagnostics Completes Private Placement Of Debentures For US$0.5 Million 23
VentriPoint Diagnostics Completes Private Placement Of Debentures For US$0.5 Million 24
VentriPoint Diagnostics Completes Private Placement Of Debentures For US$0.3 Million 26
VentriPoint Diagnostics Completes Private Placement Of Debentures For US$0.75 Million 27
VentriPoint Diagnostics Ltd – Key Competitors 28
VentriPoint Diagnostics Ltd – Key Employees 29
VentriPoint Diagnostics Ltd – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Recent Developments 31
Corporate Communications 31
Oct 17, 2018: Ventripoint Diagnostics announces new marketing manager and provides corporate update on sales 31
May 23, 2018: Ventripoint Adds Experienced Cardiac Sonographer to the Installation and Training Team 32
Jan 10, 2018: Ventripoint Appoints Head of Sales for North America 33
Dec 19, 2017: Ventripoint Diagnostics Provides Corporate Update 34
Jul 20, 2017: A Third Highly Successful Ultrasound Executive joins Ventripoint 35
Jun 21, 2017: Highly Successful Global Industry Sales & Marketing Executives Hired by Ventripoint 36
Product News 37
Nov 27, 2017: Ventripoint Invents a New Way to Track Ultrasound Probes That Will Speed up Exams 37
Other Significant Developments 38
Aug 13, 2018: Ventripoint provides corporate update on development of next-generation products 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
VentriPoint Diagnostics Ltd, Medical Equipment, Key Facts 2
VentriPoint Diagnostics Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
VentriPoint Diagnostics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
VentriPoint Diagnostics Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
VentriPoint Diagnostics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
VentriPoint Diagnostics Ltd, Deals By Market, 2012 to YTD 2018 8
VentriPoint Diagnostics Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
VentriPoint Diagnostics Enters into Licensing Agreement with University of Washington 10
VentriPoint Diagnostics Enters Into Co-Development Agreement For 2D Ultrasound-VMS 11
VentriPoint Diagnostics Raise USD0.3 Million in Private Placement of Units 12
Ventripoint Diagnostics to Raise USD2.4 Million in Private Placement of Units 13
Ventripoint Diagnostics Raises USD0.2 Million in First Tranche Private Placement of Shares 14
Ventripoint Diagnostics Raises USD2.3 Million in Private Placement of Units 15
Ventripoint Diagnostics to Raise USD3.7 Million in Private Placement of Units 16
VentriPoint Diagnostics Raises USD1.75 Million in First Tranche of Private Placement of Units 17
VentriPoint Diagnostics Completes Second Tranche Of Private Placement Of Units For US$0.05 Million 19
VentriPoint Completes Second Tranche Of Private Placement Of Units For US$0.35 Million 21
VentriPoint Diagnostics Completes Final Tranche Private Placement Of Units For US$1.6 Million 22
VentriPoint Diagnostics Completes Private Placement Of Debentures For US$0.5 Million 23
VentriPoint Diagnostics Completes Private Placement Of Debentures For US$0.5 Million 24
VentriPoint Diagnostics Completes Private Placement Of Debentures For US$0.3 Million 26
VentriPoint Diagnostics Completes Private Placement Of Debentures For US$0.75 Million 27
VentriPoint Diagnostics Ltd, Key Competitors 28
VentriPoint Diagnostics Ltd, Key Employees 29
VentriPoint Diagnostics Ltd, Subsidiaries 30

List of Figures
VentriPoint Diagnostics Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
VentriPoint Diagnostics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
VentriPoint Diagnostics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
VentriPoint Diagnostics Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
VentriPoint Diagnostics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
VentriPoint Diagnostics Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
VentriPoint Diagnostics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
VentriPoint Diagnostics Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[VentriPoint Diagnostics Ltd:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • United States Steel Corp (X):企業の財務・戦略的SWOT分析
    United States Steel Corp (X) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • RF Surgical Systems Inc-医療機器分野:企業M&A・提携分析
    Summary RF Surgical Systems Inc (RF Surgical Systems), a subsidiary of Medtronic Plc is a medical equipment company that provides retained surgical sponge detection system. The company’s products include RF assure delivery system, RF assure detection system X, and RFDETECT premium. Its RF assures de …
  • Biodesix Inc:医療機器:M&Aディール及び事業提携情報
    Summary Biodesix Inc (Biodesix) is a molecular diagnostics company which discovers, develops and commercializes multivariate protein and genomic diagnostic blood tests in oncology for patients and doctors to enable precision medicine. These tests are used for early detection of diseases, diagnosis a …
  • CMP Pharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary CMP Pharma Inc (CMP Pharma), formerly Carolina Medical Products Company Inc is a specialty pharmaceutical company that develops and manufactures generic prescription, non-prescription and skin care products. The company’s prescription products include SPS suspension, isoniazid oral solution …
  • Comet Ridge Ltd (COI):企業の財務・戦略的SWOT分析
    Summary Comet Ridge Ltd (CRL) is an oil and gas exploration and production company that acquires, explores and develops oil and gas properties. The company holds interests in Mahalo project located in the Denison trough area of Queensland's Bowen Basin near Rolleston. It also holds interest in PEL 6 …
  • BankUnited Inc:企業のM&A・事業提携・投資動向
    BankUnited Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BankUnited Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Intermediate Capital Group Plc:企業の戦略・SWOT・財務情報
    Intermediate Capital Group Plc - Strategy, SWOT and Corporate Finance Report Summary Intermediate Capital Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • CeoTronics AG (CEK):企業の財務・戦略的SWOT分析
    CeoTronics AG (CEK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Regeneron Pharmaceuticals Inc (REGN):製薬・医療:M&Aディール及び事業提携情報
    Summary Regeneron Pharmaceuticals Inc (Regeneron) is a biopharmaceutical company, which discovers, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. The company’s six US FDA-approved medicines and product candidates in development help patients wit …
  • CorMedix Inc (CRMD):企業の財務・戦略的SWOT分析
    Summary CorMedix Inc (CorMedix) is a commercial-stage pharmaceutical company that develops and commercializes therapeutic products for prevention and treatment of cardiac, renal and infectious diseases. The company offers neutrolin, a non-antibiotic anti-infective developed as a preventative solutio …
  • Quadrise Fuels International Plc (QFI)-石油・ガス分野:企業M&A・提携分析
    Summary Quadrise Fuels International Plc (QFI), formerly Zareba Plc, is an oil-in-water emulsified fuel developer that manufactures and markets MSAR (Multiphase Superfine Atomised Residue), an emulsion fuel as a low cost substitute for conventional heavy fuel oil (HFO) for use in power generation pl …
  • Rad Source Technologies Inc:企業の戦略的SWOT分析
    Rad Source Technologies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Avalon Oil & Gas Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Avalon Oil & Gas Inc (Avalon), formerly Snow Runner (USA) Inc is an oil and gas company that develops and operates crude oil and natural gas properties. The company acquires, produces and develops oil and natural gas reserves. It offers reservoir maintenance and technologies to produce portf …
  • Seegene Inc (096530):企業の財務・戦略的SWOT分析
    Summary Seegene Inc (Seegene) is a diagnostic company that develops molecular diagnostic reagents. The company provides products such as seeplex, anyplex and magicplex among others. It develops ACP, DPO, READ, MuDT and TOCE technologies that enables to detect multiple pathogens in single reactions u …
  • Xvivo Perfusion AB (XVIVO):企業の財務・戦略的SWOT分析
    Summary Xvivo Perfusion AB (Xvivo), a subsidiary of Bure Equity AB is a medical technology company that provides organ transplantation solutions. The company develops organ preservation products such as perfadex and silicone tubing sets and normothermic perfusion products. It offers normothermic per …
  • NG Biotech:企業の製品パイプライン分析
    Summary NG Biotech (NG Biotech) is a biotech company that develops and manufactures novel in vitro diagnostic tools for therapy monitoring. The company’s products include whole blood pregnancy tests, M-health malaria tests, NG Test readers, antibiotic resistance tests, and OTC tests. It also develop …
  • Maines Paper & Foodservice, Inc.:企業の戦略・SWOT・財務情報
    Maines Paper & Foodservice, Inc. - Strategy, SWOT and Corporate Finance Report Summary Maines Paper & Foodservice, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • American Eagle Outfitters Inc:企業の戦略・SWOT・財務情報
    American Eagle Outfitters Inc - Strategy, SWOT and Corporate Finance Report Summary American Eagle Outfitters Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • CEL-SCI Corp (CVM):企業の財務・戦略的SWOT分析
    CEL-SCI Corp (CVM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Flight Centre Travel Group Limited (FLT):企業の財務・戦略的SWOT分析
    Flight Centre Travel Group Limited (FLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆